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Neural tube defects (NTDs), major congenital anomalies of
the central nervous system, result from failure of the neural tube
to close between the 3rd and 4th week of gestation and include
spina biﬁda, anencephaly, and encephalocele.1 Because previous
epidemiological studies demonstrated that low folic acid intake
conclusively increases the risk of NTDs, intake of folic acid is
recommended worldwide for women during their reproductive
years.2
Natural folate contained in foods has rather low and variable
bioavailability compared with pure folic acid, and supplementa-
tion of folic acid is recommended to increase plasma folate
levels.2 Accordingly, the Centers for Disease Control in the
United States recommended intake of folic acid supplements in
1992 to all potentially pregnant women because the critical period
for NTDs occurs before pregnancy is recognized by many
women. Following this global trend, the Japanese Government in
2000 recommended intake of folic acid supplements during the
period from 1 month before pregnancy to 3 months of pregnancy
for potentially pregnant women.3 The guideline recommends
intake of 400 µg of folic acid supplement per day, in addition to
dietary intake of folic acids. Despite the unequivocal beneﬁts of
folic acid supplementation, use of the supplement, in particular
during the recommended period, has not increased substantially.
For example, a nationwide survey in Japan demonstrated that
about 85% of pregnant women took folic acid supplements during
pregnancy, although only 37% consumed them prior to pregnancy
and more than half of them consumed the supplements even after
4 months of pregnancy.3 The pregnant women who did not
comply with the guideline tended to be young, multigravida,
lacked knowledge of the beneﬁt of the intake, and had never
used supplements (other than folic acid) before pregnancy.3
The primary limitation of supplementation is that not all women
will comply and this is most likely to be problematic among
low-income groups who could beneﬁt the most.2 Therefore,
fortiﬁcation of the food supply with folic acid (eg, in ﬂour or rice)
has been mandatory in more than 80 countries to increase the
population’s intake of folic acid, and this intervention was
successful in reducing the prevalence of NTDs.2,4
Recent epidemiological studies also suggest that low intake of
folic acid is associated with increased risk of other congenital
anomalies, such as congenital heart diseases and orofacial clefts.
In this issue, therefore, Ito et al examined the associations
between serum folate concentrations measured at a mean of 10.8
weeks of gestation and various congenital anomalies, including
NTDs, during the period from 2003 to 2012 in a large birth-
cohort in Hokkaido, Japan.5 However, it seemed that they failed
to evaluate the associations and provide meaningful information
because of some bias and lack of power. I agree with their
opinion that case-control or case-cohort study design is needed to
evaluate the hypothesis, but I wonder why they did not evaluate
the associations between intake of folic acid supplements,
hopefully during the recommended period, and the outcomes,
which can reduce non-diﬀerential exposure misclassiﬁcation.
Many previous epidemiological studies used intake of supple-
ments as an exposure indicator, and it is uncertain whether
“serum” folate intake (not red blood cell concentrations that
can represent long-term levels) at 10.8 weeks of gestation can
represent folate levels during the critical period of exposure.
Moreover, they discussed that only 0.7% of the participants
were at the deﬁciency level for folic acid (less than 6.8 nmol=L in
serum levels) according to the WHO criteria,5 but the guideline
was for the population at all age groups to prevent macrocytic
anemia.6 The required level for women of reproductive age is
much higher according to the guideline. Although no serum
folate threshold is recommended, the red blood cell threshold
for women of reproductive age is about four times higher
compared with that for the population at all age groups to deﬁne
folate insuﬃciency.6 Considering that median serum folate level
of the study participants was 16.6 (interquartile range, 13.4–21.5)
nmol=L,5 most of the participants in this cohort would be
classiﬁed as having an insuﬃcient level of folic acid to prevent
NTDs.
When we look at long-term trends of NTDs in Japan,
prevalence of NTDs did not decline, despite the recommendation
of supplement intake by the Japanese Government in 2000. As
shown in Figure 1, mortality owing to NTDs, in particular spina
biﬁda, declined in parallel with the decreasing trend of infant
mortality, while prevalence of NTDs did not. This situation is
consistent with long-term trends in the prevalence of NTDs in
Europe, where mandatory fortiﬁcation programs do not yet exist.7
Despite longstanding recommendations aimed at promoting
periconceptional folic acid supplementation and existence of
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“voluntary” folic acid fortiﬁcation, the prevalence of NTDs,
including fetal deaths (around 9 per 10,000 births), did not
decline over those 20 years.7 Some may argue that the prevalence
in Japan is already low compared with that in Europe, so
supplementation of folic acid is not eﬀective. But the prevalences
shown in Figure 1 do not include numbers of NTDs from
fetal deaths, and a previous case-control study in Japan also
demonstrated that lack of intake of folic acid supplements
increased the risk of NTDs4; thus, folic acid supplementation
would be eﬀective even for women of reproductive age in Japan.
Considering the inadequate supplement intake during the
periconceptional period in Japan3 and the fact that the level for
folic acid of most of the pregnant women observed in the
Hokkaido study would be classiﬁed as insuﬃcient, recommenda-
tion of intake of folic acid supplements would not be adequate as
a public health strategy. Rather, the mandatory folate fortiﬁcation
program would potentially be the most eﬀective strategy because
it can reach almost the entire population and does not depend
on constant education and motivation.2–4 Thus, reductions in
prevalence of NTDs would be possible even in Japan.
What should we do as epidemiologists? It is necessary to
conduct further studies to accumulate more evidence on the
associations of folic acid intake and NTDs and other congenital
anomalies, as Ito et al conducted. Epidemiology not only
elucidates the etiology of the disease, but can also evaluate the
beneﬁcial eﬀect of political intervention on human health.
Therefore, we should return to review the trends of NTDs after
several interventions. At this stage, however, when we look at the
trend of NTDs in Figure 1, we would ultimately disagree with the
beneﬁcial eﬀect of the recommendation in 2000.
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Figure 1. Trends in prevalence and mortality under 1 year of age of neutral tube defects (NTDs), as well as infant mortality in
Japan from 1994 to 2016. The units are one per 1,000 births for infant mortality, one per 100,000 births for mortality
owing to NTDs and spina biﬁda, and one per 10,000 births for prevalence. The International Classiﬁcation of Diseases-
10 codes are Q00, Q01, and Q05 for NTDs and Q05 for spina biﬁda. Mortality information was obtained from Vital
Statistics from Ministry of Health, Labour, and Welfare in Japan. Prevalence for NTDs ( ) and spina biﬁda ( )
information was obtained from the Annual Report 2009–2014 published by the International Clearinghouse for Birth
Defects Surveillance and Research and prevalence before 2006 was average of the prevalence during the 5 years
(eg, 5-year average of the prevalence from 2002 to 2006 is shown in 2004).
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